News

Published on 17 Mar 2023 on Insider Monkey via Yahoo Finance

MacroGenics, Inc. (NASDAQ:MGNX) Q4 2022 Earnings Call Transcript


Article preview image

MacroGenics, Inc. (NASDAQ:MGNX) Q4 2022 Earnings Call Transcript March 15, 2023

Operator: Good afternoon. We will begin the MacroGenics 2022 Fourth Quarter Corporate Progress and Financial Results Conference Call in just a moment. At this point, I will turn the call over to Jim Karrels, Senior Vice President, Chief Financial Officer of MacroGenics.

Jim Karrels: Thank you, operator. Good afternoon, and welcome to MacroGenics conference call to discuss our fourth quarter 2022 financial and operational results. For anyone who's not had the chance to review these results, we issued a press release this afternoon outlining today's announcements, which is available under the Investors tab on our website at macrogenics.com. You may also listen to this conference call via webcast on our website, where it will be archived for 30 days beginning approximately 2 hours after the call is completed. I would like to alert listeners that today's discussion will include statements about the company's future expectations, plans, and prospects that constitute forward-looking statements for purposes of the safe harbor provision under the Private Securities Litigation Reform Act of 1995.

NASDAQ.MGNX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
The past year for MacroGenics (NASDAQ:MGNX) investors has not been profitable

Even the best investor on earth makes unsuccessful investments. But it should be a priority to av...

Simply Wall St. · via Yahoo Finance 17 Feb 2025

Macrogenics Inc (MGNX) Q3 2024 Earnings Call Highlights: Revenue Surge and...

Macrogenics Inc (MGNX) reports a remarkable revenue increase driven by milestone payments, while...

GuruFocus.com · via Yahoo Finance 6 Nov 2024

Earnings To Watch: Macrogenics Inc (MGNX) Reports Q3 2024 Result

Macrogenics Inc (NASDAQ:MGNX) is set to release its Q3 2024 earnings on Nov 5, 2024. The consensu...

GuruFocus.com · via Yahoo Finance 4 Nov 2024

Shareholders in MacroGenics (NASDAQ:MGNX) are in the red if they invested three...

This month, we saw the MacroGenics, Inc. (NASDAQ:MGNX) up an impressive 37%. But that doesn't cha...

Simply Wall St. · via Yahoo Finance 20 Jun 2024

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.32% By Investing.com

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.32%

Investing.com 10 May 2024

MacroGenics reports progress in prostate cancer study By Investing.com

MacroGenics, Inc. (NASDAQ: NASDAQ:MGNX), a biopharmaceutical company specializing in the developm...

Investing.com 10 May 2024

Why Is MacroGenics Stock Nosediving On Friday? - Macrogenics (NASDAQ:MGNX)

On Thursday, MacroGenics Inc MGNX released interim data from the TAMARACK Phase 2 study of vobram...

Benzinga 10 May 2024

MacroGenics, Inc. (NASDAQ:MGNX) Q1 2024 Earnings Call Transcript

MacroGenics, Inc. (NASDAQ:MGNX) Q1 2024 Earnings Call Transcript May 10, 2024 MacroGenics, Inc. i...

Insider Monkey via Yahoo Finance 10 May 2024

After-hours movers: Akamai Technologies, Unity, Macrogenics and more By Investing.com

After-hours movers: Akamai Technologies, Unity, Macrogenics and more

Investing.com 9 May 2024

MacroGenics senior VP sells over $799k in company stock By Investing.com

Stuart Peters, Senior VP and General Counsel at MacroGenics Inc (NASDAQ:MGNX), sold a significant...

Investing.com 9 Apr 2024